Exozymes Inc. has announced an update to the compensation package for its Chief Executive Officer, Michael Heltzen, effective June 17, 2025. The new package includes an increased annual base salary of $450,000 and a one-time bonus of $250,000. Additionally, Heltzen has been granted options to purchase 235,817 shares of the company's common stock at an exercise price of $12.40 per share. These stock options will vest over a four-year period, starting on July 1, 2025, with equal quarterly installments. The options are set to expire on June 29, 2032.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exozymes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-015782), on June 20, 2025, and is solely responsible for the information contained therein.